Clinical Trials in Nashville

Showing 521-540 of 20,298 trials

IKS014 in Advanced Solid Tumors That Express HER2

NCT05872295

This study will evaluate the recommended dose for further clinical development, safety, tolerability, anti-tumor activity, immunogenicity, pharmacokinetics and pharmacodynamics of IKS014, a HER2 targeting antibody-drug conjugate, in patients with advanced solid tumors.

Breast CancerGastric CancerGastroesophageal-junction Cancer

Iksuda Therapeutics Ltd.165 participantsStarted Sep 2023

Newport Beach, California, United States • Boston, Massachusetts, United States • Nashville, Tennessee, United States +10 more locations

Active Not RecruitingPhase 1< 1 mile

A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma

NCT04722146

The purpose of this study is to characterize the safety and tolerability of teclistamab when administered in different combination regimen and to identify the optimal dose(s) of teclistamab combination regimens.

Multiple Myeloma

Janssen Research & Development, LLC140 participantsStarted Mar 2021

Birmingham, Alabama, United States • San Francisco, California, United States • Denver, Colorado, United States +24 more locations

IKS014 in Advanced Solid Tumors That Express HER2

A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma

Find Trials by Condition in Nashville

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer

A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

A Study of Navenibart (STAR-0215) in Participants With Hereditary Angioedema

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

An Extension Study of Donidalorsen (IONIS-PKK-LRx) in Participants With Hereditary Angioedema

A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension

Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

Neuromodulation and Neurorehabilitation for mTBI

Clinical Study of Edwards Cardioband FIT Valve Repair System

Acute Normovolemic Hemodilution in High Risk Cardiac Surgery Patients.

STrategies for Catheter Ablation of peRsistent Atrial Fibrlllation

A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers